Plus500 does not provide CFD services to residents of the United States. Visit our U.S. website at

Pfizer Soars With Covid-19 Vaccine Announcement

Plus500 | Tuesday 10 November 2020

Pharmaceutical giant Pfizer (PFE) brought welcoming news to global markets, announcing that their COVID-19 vaccine trials showed a 90% success rate.

Covid-19 vaccine

Since early March this year, many pharmaceutical companies raced to find an effective vaccine against COVID-19. This renewed hope from Pfizer, together with German biotechnology firm BioNTech saw markets rally, despite not yet receiving FDA approval. Following the announcement, Pfizer soared 7.6%, leaving traders to wonder if other pharmaceutical companies will follow suit with other Coronavirus vaccines. 

Unlike Pfizer, other biotech companies took the plunge as Biogen’s (BIIB) shares dropped 28.1% and AstraZeneca (AZN.ST) shed 2.6% before recovering 2.2% during Tuesday morning’s trading. 

US Market Reaction

The announcement saw many US indices climb, such as the S&P500 (USA500) gaining +3.9% while the DJIA (USA 30 - Wall Street) jumped 2.3%.

However, some companies who gained a mid-year boost during national lockdowns dropped during Monday’s trading, such as: 

While these popular stocks dropped, entertainment shares, such as Cinemark (CNK) jumped 45% on hopes of reopening theaters. 

Futures Rise and Fall

Some indices experienced mid afternoon losses on Monday following their morning gains, the FTSE 100 (UK100) ended the day up 3.06%, Fibi (Italy40) was up 3.24% & Spain's IBEX 35 (Spain 35) closed 7.0% higher.

Following recent losses, Oil (CL) opened at $37.3, climbing to $41.3 before tapering off and closing at 39.8, locking in a 6.7% climb during Monday’s trading.

While yesterday’s events saw markets rise and fall, it is unclear how Pfizer's announcement will affect future markets, especially in Europe which is experiencing a wave of renewed restrictions.

This information is written by Plus500 Ltd. The information is provided for general purposes only, and does not take into account any personal circumstances or objectives. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. No representation or warranty is given as to the accuracy or completeness of this information. It does not constitute financial, investment or other advice on which you can rely. Any references to past performance, historical returns, future projections, and statistical forecasts are no guarantee of future returns or future performance. Plus500 will not be held responsible for any use that may be made of this information and for any consequences that may result from such use. Hence, any person acting based on this information does so at their own discretion. The information has not been prepared in accordance with legal requirements designed to promote the independence of investment research.

Need Help?
24/7 Support